IL-2R alpha | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

7,961 results for “IL-2R alpha”

Trials

View all 3873 →

Zenapax to Treat Multiple Sclerosis

22 participants · First posted Nov 4, 1999

OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

252 participants · First posted Dec 9, 2013

Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides

15 participants · First posted Sep 2, 2022

Drugs

View all 1939 →

Interleukin-1 alpha, human recombinant

IFN-alpha + IL-7 + IL-15-sushi + Fc-OX40L

IFN-alpha + IL-8 + IL-12 cytokine derivative (Solid tumor)

Organizations

View all 37 →

Simcha Il 18, Inc.

United States

Alpha Metallurgical

United States

Zeno Alpha, Inc.

United States

News

View all 2112 →

Innovent Expands Phase 3 MarsLight-11 Trial of IBI363/TAK-928 to Non-Squamous NSCLC

Anaveon Presents Positive ANV600 Clinical Data at ASCO 2026, Seeks Partners for Oncology Portfolio

EOM Pharmaceuticals Receives FDA Clearance for Phase 2a Cancer Cachexia Trial of EOM613

Page 1 of 797